MNA
TECH icon

Manning & Napier Advisors’s Bio-Techne TECH Stock Holding History

Manning & Napier Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Buy
+52
New +$2.81K ﹤0.01% 632

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Manning & Napier Advisors's TECH Position: Q2 2026 in Review

Manning & Napier Advisors opened a new position in Bio-Techne (TECH) in Q2 2026: 52 shares worth $3.69K. The stake represents ﹤0.01% of the portfolio and ranks #632 among its holdings.

593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Manning & Napier Advisors held 52 shares of Bio-Techne worth $3.69K as of Q2 2026.
  • Bio-Techne was a new Manning & Napier Advisors position in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #632 holding.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.